Computational Medicine and Drug Designing Software Market
Computational Medicine and Drug Designing
Software Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Computational Medicine and Drug Designing Software
Market Size and Growth
The Computational Medicine and Drug Designing Software market is experiencing significant growth, driven by advances in artificial intelligence and big data analytics. The market size is projected to reach approximately $7 billion by 2025, reflecting a compound annual growth rate (CAGR) of 12%.
Increased demand for personalized medicine fuels innovation and investment.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Entelos
◍ Crown Bioscience
◍ Chemical Computing Group
◍ Nimbus Therapeutics
◍ Schrodinger
◍ Dassault Systemes
◍ Genedata
◍ Biognos
◍ Leadscope
◍ Rhenovia Pharma Limited
◍ Compugen
◍ Certara LP
◍ Prosarix
◍ Simulations Plus
◍ Strand Life Sciences
The Computational Medicine and Drug Designing Software Market features companies like Entelos, Crown Bioscience, and Schrodinger, which leverage advanced modeling and simulation to streamline drug discovery. Their innovations enhance efficiency and accuracy, driving market growth. Sales figures for some include:
- Certara: ~$220 million
- Schrodinger: ~$190 million
- Genedata: ~$30 million
Request Sample Report
Market Segmentation
By Application
By Product
On-premise ◍ Drug Discovery and Development
◍ Cloud-based
◍ Computational Physiological Medicine
◍ Disease Modeling
◍ Medical Imaging
◍ Predictive Analysis of Drug Targets Request Sample Report
Market Growth
Request Sample Report
$ 0.00 Million USD
